The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 27, 2018

Filed:

Apr. 02, 2012
Applicants:

Peter Bruin, Groningen, NL;

Audrey Petit, Groningen, NL;

Mike DE Leeuw, Groningen, NL;

Martin Piest, Groningen, NL;

Ronald Meijboom, Groningen, NL;

Inventors:

Peter Bruin, Groningen, NL;

Audrey Petit, Groningen, NL;

Mike De Leeuw, Groningen, NL;

Martin Piest, Groningen, NL;

Ronald Meijboom, Groningen, NL;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/167 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 47/34 (2017.01); A61K 49/04 (2006.01); C08G 63/664 (2006.01); C08G 63/682 (2006.01); A61K 31/415 (2006.01); A61K 31/573 (2006.01); A61K 38/13 (2006.01); A61K 38/38 (2006.01); A61K 38/47 (2006.01); A61K 39/395 (2006.01); A61K 51/06 (2006.01); A61K 47/30 (2006.01); A61K 47/50 (2017.01);
U.S. Cl.
CPC ...
A61K 31/167 (2013.01); A61K 9/0024 (2013.01); A61K 9/06 (2013.01); A61K 31/415 (2013.01); A61K 31/573 (2013.01); A61K 38/13 (2013.01); A61K 38/385 (2013.01); A61K 38/47 (2013.01); A61K 39/395 (2013.01); A61K 47/34 (2013.01); A61K 49/04 (2013.01); A61K 49/0442 (2013.01); A61K 49/0457 (2013.01); C08G 63/664 (2013.01); C08G 63/6822 (2013.01); A61K 47/30 (2013.01); A61K 47/50 (2017.08); A61K 51/06 (2013.01); A61K 51/065 (2013.01);
Abstract

A special class of drug-depot forming triblock copolymers which are very suitable for the loading, containment and releasing of sensitive drugs such as proteins from biodegradable, injectable drug depots. How to visualize these depots for various imaging related purposes is described. A composition comprising a tri-block copolymer according to formula 1 B-A-B (1), wherein A stands for a linear poly-(ethylene glycol) block and wherein B stands for wherein B stands for a poly(lactide-co-ε-caprolactone) block, wherein the hydroxyl end-groups of the tri-block copolymer are at least partially acylated with an optionally substituted acyl having 2 to 12 C-atoms, C-atoms of the substituents included; an active ingredient, preferably a pharmaceutically active ingredient and a solvent, wherein the block ratio of the tri-block copolymer, which ratio is defined as the ratio between the sum of the average molecular weight of the B-blocks and the sum of the average molecular weight of the A-block ranges from 1.4 to 3.5. This composition is suitable for controlled release of a pharmaceutically active ingredient.


Find Patent Forward Citations

Loading…